Select Page

Global cell isolation market size is expected to reach $12.6 billion by 2023. The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.

Explore report sample at:

Based on product, the cell isolation market is categorized into consumables and instruments. Consumables generated revenue of more than $2.5 billion, accounting for 61.4% share, in the market in 2017, owing to the increased demand for consumables, such as reagents, kits, media, and sera, for cell isolation techniques.

The cell isolation market is also categorized into human cells and animal cells. During the forecast period, the market is expected to witness higher growth in human cell isolation, with a CAGR of 19.9%. Advancements in stem cell technologies for the treatment of various diseases are expected to drive the cell isolation market growth for this category.

Based on technique, the market is categorized into centrifugation, surface marker, and filtration. Centrifugation technique is expected to continue generating the largest revenue in the cell isolation market in the coming years. The technique contributed 42.2% share to the market in 2017. This can be mainly attributed to the lower cost of the centrifugation technique as compared to other techniques.

Browse report at:

In June 2016, Thermo Fisher Scientific Inc. entered into a strategic partnership agreement with Cytonome/ST to be the exclusive distributor of a new line of flow cytometry cell-sorting technology that companies would co-develop. The key objective of the partnership was development of innovative and easy-to-use benchtop cell-sorting platforms.

Some of the other key players operating in the cell isolation industry are Terumo Corporation, General Electric Company, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Danaher Corporation, Merck KGaA, Miltenyi Biotec GmbH, and Becton, Dickinson and Company.